VALNEVA AUSTRIA GMBH

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 33222
 
  
 
C07K PEPTIDES 14122
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 8159
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 594
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 594
 
  
 
C07D HETEROCYCLIC COMPOUNDS 2160
 
  
 
C09K MATERIALS FOR APPLICATIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR293
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205
 
  
 
H01L SEMICONDUCTOR DEVICES; ELECTRIC SOLID STATE DEVICES NOT OTHERWISE PROVIDED FOR 1361

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0296,656 ALUMINUM COMPOUNDS FOR USE IN THERAPEUTICS AND VACCINESMar 27, 17Oct 19, 17[A61K, C12N]
2016/0324,959 ALUMINUM COMPOUNDS FOR USE IN THERAPEUTICS AND VACCINESJul 29, 16Nov 10, 16[A61K, C12N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9913898 Aluminum compounds for use in therapeutics and vaccinesJul 29, 16Mar 13, 18[C09K, A61K, C07D, C12N]
9895437 Aluminum compounds for use in therapeutics and vaccinesApr 18, 12Feb 20, 18[A61K, C12N, C07K]
9884115 Aluminum compounds for use in therapeutics and vaccinesOct 02, 15Feb 06, 18[C09K, A61K, H01L, C07D, C12N]
9598472 and uses thereofSep 05, 11Mar 21, 17[A61K, C07K]
9492537 Methods and compositions involving immunostimulatory oligodeoxynucleotidesDec 30, 14Nov 15, 16[A61K, C07H, C12N]
9359412 OprF/I fusion proteins, their preparation and useMar 19, 12Jun 07, 16[A61K, C07K]
9248180 IC31 nanoparticlesApr 22, 14Feb 02, 16[A61K, C12N]
8986704 Mutant fragments of OspA and methods and uses relating theretoMar 14, 13Mar 24, 15[A61K, C12N, C07K]
8952135 antigens I and IIMay 06, 13Feb 10, 15[A61K, C12P, C07K]
8945591 Methods and compositions involving immunostimulatory oligodeoxynucleotidesMar 06, 13Feb 03, 15[A61K, C07H]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0362,480 NOVEL OPRF/I FUSION PROTEINS, THEIR PREPARATION AND USEAbandonedMay 16, 16Dec 15, 16[C07K]
2015/0250,865 MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETOAbandonedFeb 17, 15Sep 10, 15[A61K, C07K]
2015/0232,517 MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETOAbandonedJul 08, 13Aug 20, 15[A61K, C12P, C07K]
2015/0010,595 VACCINES COMPRISING AN IMMUNOSTIMULATORY PEPTIDE AND AN IMMUNOSTIMULATORY OLIGODEOXYNUCLEIC ACID MOLECULEAbandonedJun 11, 14Jan 08, 15[A61K, C12N]
2014/0212,448 KLEBSIELLA ANTIGENSAbandonedDec 11, 13Jul 31, 14[A61K, C07K]
8637052 antigensExpiredJul 06, 12Jan 28, 14[A61K, C07K]
2014/0017,270 SMALL STREPTOCOCCUS PYOGENES ANTIGENS AND THEIR USEAbandonedAug 15, 13Jan 16, 14[C07K]
8617574 antigensExpiredFeb 15, 10Dec 31, 13[A61K, C12P, C07K]
2013/0280,288 PEPTIDES PROTECTIVE AGAINST S. PNEUMONIAE AND COMPOSITIONS, METHODS AND USES RELATING THERETOAbandonedApr 17, 13Oct 24, 13[A61K]
2013/0266,575 OprF/I AGENTS AND USE THEREOF IN HOSPITALIZED AND OTHER PATIENTSAbandonedMar 12, 13Oct 10, 13[A61K]
8529910 Enterococcus antigensExpiredMar 28, 11Sep 10, 13[A61K, C07K]
7638136 Streptococcus pyogene antigensExpiredMar 02, 04Dec 29, 09[A61K, C07H, C12P, C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.